Literature DB >> 23471064

Life sciences venture capital in emerging markets.

Justin Chakma, Stephen M Sammut, Ajay Agrawal.   

Abstract

Mesh：

Year:  2013        PMID： 23471064     DOI： 10.1038/nbt.2529

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  10 in total

1.  New startup models emerge as investor landscape shifts.

Authors:  Brady Huggett
Journal:  Nat Biotechnol       Date:  2011-12-08       Impact factor: 54.908

2.  South-South entrepreneurial collaboration in health biotech.

Authors:  Halla Thorsteinsdóttir; Christina C Melon; Monali Ray; Sharon Chakkalackal; Michelle Li; Jan E Cooper; Jennifer Chadder; Tirso W Saenz; Maria Carlota de Souza Paula; Wen Ke; Lexuan Li; Magdy A Madkour; Sahar Aly; Nefertiti El-Nikhely; Sachin Chaturvedi; Victor Konde; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

3.  Daniel Vasella.

Authors:  Bethan Hughes
Journal:  Nat Rev Drug Discov       Date:  2010-02       Impact factor: 84.694

4.  China: a life sciences giant.

Authors: 
Journal:  Nat Rev Microbiol       Date:  2010-05       Impact factor: 60.633

5.  India's health biotech sector at a crossroads.

Authors:  Sarah E Frew; Rahim Rezaie; Stephen M Sammut; Monali Ray; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2007-04       Impact factor: 54.908

6.  Small but tenacious: South Africa's health biotech sector.

Authors:  Sara Al-Bader; Sarah E Frew; Insiya Essajee; Victor Y Liu; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2009-05       Impact factor: 54.908

Review 7.  Brazilian health biotech--fostering crosstalk between public and private sectors.

Authors:  Rahim Rezaie; Sarah E Frew; Stephen M Sammut; Maya R Maliakkal; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2008-06       Impact factor: 54.908

8.  A survey of South-North health biotech collaboration.

Authors:  Christina C Melon; Monali Ray; Sharon Chakkalackal; Michelle Li; Jan E Cooper; Jennifer Chadder; Wen Ke; Lexuan Li; Magdy A Madkour; Sahar Aly; Nefertiti Adly; Sachin Chaturvedi; Victor Konde; Abdallah S Daar; Peter A Singer; Halla Thorsteinsdóttir
Journal:  Nat Biotechnol       Date:  2009-03       Impact factor: 54.908

9.  Innovative drug R&D in China.

Authors:  Jingzong Qi; Qingli Wang; Zhenhang Yu; Xin Chen; Fengshan Wang
Journal:  Nat Rev Drug Discov       Date:  2011-05       Impact factor: 84.694

Review 10.  Chinese health biotech and the billion-patient market.

Authors:  Sarah E Frew; Stephen M Sammut; Alysha F Shore; Joshua K Ramjist; Sara Al-Bader; Rahim Rezaie; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2008-01       Impact factor: 54.908
  10 in total
  6 in total

1.  Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s).

Authors:  Hao Hu; Chao-Chen Chung
Journal:  Int J Health Policy Manag       Date:  2015-09-03

2.  Market watch: Evolution of Chinese bioclusters as a framework for investment policies in emerging markets.

Authors:  Ajay Gautam
Journal:  Nat Rev Drug Discov       Date:  2014-12-12       Impact factor: 84.694

3.  The political economy of healthcare reform in China: negotiating public and private.

Authors:  Arthur Daemmrich
Journal:  Springerplus       Date:  2013-09-10

4.  Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation.

Authors:  Yun-Zhen Shi; Hao Hu; Chunming Wang
Journal:  Global Health       Date:  2014-11-19       Impact factor: 4.185

5.  Obstacles and opportunities in Chinese pharmaceutical innovation.

Authors:  Jingyun Ni; Junrui Zhao; Carolina Oi Lam Ung; Yuanjia Hu; Hao Hu; Yitao Wang
Journal:  Global Health       Date:  2017-03-24       Impact factor: 4.185

6.  Healthcare reform in the United States and China: pharmaceutical market implications.

Authors:  Arthur Daemmrich; Ansuman Mohanty
Journal:  J Pharm Policy Pract       Date:  2014-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.